SEC 13F Intelligence

Columbia Asset Management / ABBV

Columbia Asset Management’s Abbvie Inc Position

Does Columbia Asset Management own Abbvie Inc (ABBV)? Yes35.3K shares worth $8M (+1.46% of its 13F portfolio) as of Q1 2026, down from 35.5K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
35.3K
% of Portfolio
+1.46%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $4MQ4 ’19: $44MQ4 ’19Q1 ’20: $48MQ2 ’20: $6MQ3 ’20: $5MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $6MQ3 ’21: $6MQ4 ’21: $8MQ4 ’21Q2 ’22: $7MQ3 ’22: $6MQ4 ’22: $7,620Q1 ’23: $7,377Q1 ’23Q2 ’23: $5,497Q3 ’23: $6,027Q4 ’23: $6,255Q1 ’24: $6,255Q1 ’24Q2 ’24: $6,953Q3 ’24: $8,053Q4 ’24: $7MQ1 ’25: $8MQ1 ’25Q2 ’25: $7MQ3 ’25: $8MQ4 ’25: $8MQ1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202635.3K$8M+1.46%
Q4 202535.5K$8M+1.44%
Q3 202535.7K$8M+1.55%
Q2 202536.5K$7M+1.33%
Q1 202537.4K$8M+1.53%
Q4 202438.7K$7M+1.26%
Q3 202440.8K$8,053+1.40%
Q2 202440.5K$6,953+1.30%
Q1 202440.4K$6,255+1.27%
Q4 202340.4K$6,255+1.27%
Q3 202340.4K$6,027+1.33%
Q2 202340.8K$5,497+1.17%
Q1 202346.3K$7,377+1.66%
Q4 202247.1K$7,620+1.85%
Q3 202247.4K$6M+1.67%
Q2 202248.7K$7M+1.89%
Q4 202155.6K$8M+1.53%
Q3 202155.2K$6M+1.30%
Q2 202154.4K$6M+1.36%
Q1 202162.1K$7M+1.22%
Q4 202056.3K$6M+1.21%
Q3 202055.1K$5M+1.11%
Q2 202056.2K$6M+1.32%
Q1 2020100.9K$48M+11.77%
Q4 201949.4K$44M+1.05%
Q3 201947.0K$4M+0.93%
Q2 201943.6K$3M+0.83%
Q1 201936.4K$3M+0.78%
Q4 201834.6K$3M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Columbia Asset Management’s full portfolio or all institutional holders of ABBV.